Project description:Interventions: Lung Cancer group:Novel Oncolytic Virus;Colorectal Cancer group:Novel Oncolytic Virus
Primary outcome(s): objective response rate;overall survival;Quality of life;Safety;disease control rate;disease-free survival
Study Design: Single arm
| 2725682 | ecrin-mdr-crc
Project description:Description of novel bacteria via Protologger
